A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.

@article{Emsley2004ASR,
  title={A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.},
  author={Robin Emsley and H. Jadri Turner and Juan Paul Schronen and Karien Botha and Retha M Smit and Piet P. Oosthuizen},
  journal={The Journal of clinical psychiatry},
  year={2004},
  volume={65 5},
  pages={696-701}
}
BACKGROUND While the atypical antipsychotics should ultimately reduce the prevalence of tardive dyskinesia, it is likely to remain a significant clinical problem for a long time to come. No strategy has clearly emerged as the treatment of choice for tardive dyskinesia. Atypical antipsychotics have reduced propensities for producing acute extrapyramidal symptoms (EPS) and possibly tardive dyskinesia and may be effective in treating patients with established tardive dyskinesia. METHOD This 12… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

New and emerging treatments for symptomatic tardive dyskinesia

Drug design, development and therapy • 2013
View 4 Excerpts
Highly Influenced

Amisulpride withdrawal dyskinesia: a case report

Annals of general psychiatry • 2017
View 1 Excerpt

Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology • 2016

Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology • 2014

Similar Papers

Loading similar papers…